Osso VR vs Theator

Theator's buyer sits in health-system documentation and Osso's in clinical education, so nobody weighs the two against each other. A hospital system on Epic or Oracle Health with a documentation budget buys Theator. A residency program or a nursing education department buys Osso for VR procedure practice. Theator's evidence includes a 158-case study in the Journal of the American College of Surgeons, where AI-written robotic prostatectomy reports were 87.3% accurate against 72.8% for surgeon-written ones. Mayo Clinic urology and Theator authors wrote it, and the homepage figure of over 95% is the vendor's own metric. Osso lists three randomized trials of its platform, in knee replacement and tibial nailing, with skill ratings measured on simulated procedures, and Osso financed one of them. Theator has no FDA 510(k) record as of October 2026, and Osso's pages state no FDA status. Neither shows a price: Theator takes demo requests, Osso a contact form.